A Phenomenological Examination of Psilocybin and its Positive and Persisting Aftereffects
Full Text:Full Text PDF
Arfken ME. Political practice: A hermeneutic-phenomenological inquiry. Doctoral Dissertation, University of Tennessee, Knoxville, 2006.
Cohen WE and Inaba DS. Uppers, downers, all arounders: Physical and mental effects of psychoactive drugs. (5th ed.). Medford, OR: CNS Publications, Inc, 2004.
Creswell JW. Qualitative inquiry and research design: Choosing among five traditions. Thousand Oaks, CA: SAGE Publications, Inc., 1998.
Doblin R. Pahnke's "Good Friday experiment": A long-term follow-up and methodological critique. Journal of Transpersonal Psychology 1991; 23(1): 1-28.
Doblin R. Dr. Leary’s Concord prison experiment: A 34-year follow-up study. Journal of Psychoactive Drugs 1998; 30(4): 419-426.
Gasser P, Kirchner K and Passie T. LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects. Journal of Psychopharmacology 2015; 29(1): 57-68.
Griffiths RR, Johnson MW, Richards WA, Richards BD, McCann U and Jesse R. Psilocybin occasioned mystical-type experiences: Immediate and persisting dose-related effects. Psychopharmacology 2011; 218(4): 649-665.
Griffiths RR, Richards WA, Johnson MW, McCann UD and Jesse R. Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later. Journal of Psychopharmacology 2008; 22(6): 621-632.
Griffiths RR, Richards WA, McCann U and Jesse R. Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology 2006; 187(3): 268-283.
Grob CS, Danforth AL, Chopra GS, Hagerty M, McKay CR, Halberstadt AL and Greer GR. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Archives of General Psychiatry 2011; 68(1): 71-78.
Lester S. An introduction to phenomenological research. Taunton, UK: Stan Lester Developments, 1999.
MacLean KA, Johnson MW and Griffiths RR. Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness. Journal of Psychopharmacology 2011; 25(11): 1453-1461.
McCracken G. The long interview (Vol. 13). Thousand Oaks, CA: SAGE Publications, 1988.
Moreno FA, Wiegand CB, Taitano EK and Delgado PL. Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder. Journal of Clinical Psychiatry 2006; 67(11): 1735-1740.
Sessa B. Can psychedelics have a role in psychiatry once again? British Journal of Psychiatry 2005; 186: 457-458.
Sessa B. Shaping the renaissance of psychedelic research. The Lancet 2012; 380: 200-201.
Stafford, P. Psychedelics encyclopedia (3rd ed.). Berkeley, CA: Ronin Publishing, Inc, 1992.
Strassman RJ. Adverse reactions to psychedelic drugs: A review of the literature. The Journal of Nervous and Mental Disease 1984; 172(10); 577-595.
Studerus E, Gamma A, Kometer M and Vollenweider FX. (2012). Prediction of psilocybin response in healthy volunteers. PLoS ONE 2012; 7(2): e30800.